Biotechnology and Pharma Switzerland Biotechnology and Pharma Germany Biotechnology and Pharma Sweden Biotechnology and Pharma   UK Biotechnology and Pharma  Ireland Biotechnology and Pharma  France Biotechnology and Pharma Italy Biotechnology and Pharma Netherlands Biotechnology and Pharma Belgium Biotechnology and Pharma Norway Biotechnology and Pharma Denmark Biotechnology and Pharma  Austria Biotechnology and Pharma  Greece Biotechnology and Pharma Finland Biotechnology and Pharma Spain Biotechnology and Pharma Hungary Biotechnology and Pharma Russia Biotechnology and Pharma Czech Republic Biotechnology and Pharma Estonia Biotechnology and Pharma Poland Biotechnology and Pharma Portugal Biotechnology and Pharma  Slovakia Biotechnology and Pharma Lithuania Biotechnology and Pharma  Iceland Biotechnology and Pharma Slovenia Biotechnology and Pharma Bulgaria Biotechnology and Pharma Romania Biotechnologyand Pharma Macedonia Biotechnology and Pharma Albania Biotechnology and Pharma Luxembourg Biotechnology and Pharma Serbia Biotechnology and Pharma Cyprus Biotechnology and Pharma Malta Biotechnology and Pharma Belarus Biotechnology and Pharma Croatia Biotechnology and Pharma Ukraina Biotechnology and Pharma Turkey     16.05.2008 Oxford Biomedica Announces TROVAX® Phase II Trial Results in Renal Cancer to be Presented at ASCO   15.05.2008 Amgen Highlights Data to Be Presented at ASCO   15.05.2008 Overview Provided for Studies to be Presented at the 2008 American Society of Clinical Oncology Annual Meeting; and Updated Timing Provided for Ongoing Study in Early-Stage Colon Cancer   15.05.2008 Genentech Provides Update On Studies Of Investigational Biooncology Agents To Be Presented At The American Society Of Clinical Oncology Meeting   14.05.2008 Amarin announces private placement for up to $60 million   14.05.2008 Merck Cooperates With the University of Applied Science in Muenster   13.05.2008 Circadin launch rollout starts with the launch of the product in the important German market   13.05.2008 Active Biotech advances ANYARA into Phase III clinical trial   12.05.2008 Bone Medical further positive results from oral osteoporosis drug trial    09.05.2008 Oxford Biomedica Annual General Meeting   09.05.2008 MediGene Presents 3-Months Report 2008   09.05.2008 Actemra inhibits joint damage and improves physical function of patients with Rheumatoid Arthritis   08.05.2008 KeyNeurotek Pharmaceuticals AG Reports Positive Phase I Data of Its Cannabinoid Receptor-Agonist   08.05.2008 Annual General Meeting of Active Biotech AB   08.05.2008 Cytopia announces novel anti-cancer drug development collaboration   08.05.2008 Zevalin Revenues Lead Cell Therapeutics, Inc.'s First Quarter 2008 Financial Results